Medpace insider plans sale of 1,140 shares

Medpace Holdings insider Cornelius McCarthy III filed to potentially sell 1,140 common shares through Fidelity Brokerage Services on the NASDAQ around August 11, 2026, with an indicated aggregate market value of $690,121.91.

Accepted by SEC EDGAR 08/11/2026 - 05:01 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Medpace Holdings insider Cornelius McCarthy III filed to potentially sell 1,140 common shares through Fidelity Brokerage Services on the NASDAQ around August 11, 2026, with an indicated aggregate market value of $690,121.91. Medpace had 27,911,655 shares outstanding as of that filing line. The shares were acquired via a stock option exercise from the issuer on August 7, 2026 for cash. The filing also notes a prior sale of 795 common shares on August 7, 2026 for total proceeds of $465,131.45 over the last three months.

Key Figures

Shares proposed for sale: 1,140 shares Aggregate market value: $690,121.91 Shares outstanding: 27,911,655 shares +4 more

7 metrics

Shares proposed for sale 1,140 shares Common stock covered by the Form 144 filing

Aggregate market value $690,121.91 Indicated value of 1,140 shares proposed for sale

Shares outstanding 27,911,655 shares Medpace common shares outstanding referenced in the filing

Prior shares sold 795 shares Common shares sold during the past three months

Proceeds from prior sale $465,131.45 Aggregate proceeds from 795-share sale on August 7, 2026

Proposed sale date 08/11/2026 Anticipated sale date for the 1,140-share transaction

Acquisition date 08/07/2026 Date shares were acquired via stock option exercise

Key Terms

Form 144, stock option exercise, aggregate market value

3 terms

Form 144 regulatory

"144: Securities Information Common | Fidelity Brokerage"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"Common | 08/07/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 690121.91"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Medpace (MEDP) insider Cornelius McCarthy III plan to sell under this Form 144?

The Form 144 indicates a potential sale of 1,140 Medpace common shares. These shares are to be sold through Fidelity Brokerage Services on the NASDAQ, with an indicated aggregate market value of $690,121.91 as disclosed in the filing.

When were the Medpace (MEDP) shares acquired that are covered by this Form 144?

The 1,140 Medpace shares were acquired on August 7, 2026 via a stock option exercise from the issuer. The filing notes the acquisition method as a cash-based stock option exercise, providing context for the proposed resale under Form 144.

What is the proposed timing of the Medpace (MEDP) insider share sale?

The filing lists a proposed sale date of around August 11, 2026 for the 1,140 Medpace common shares. This date in the Form 144 represents the anticipated timing for the transaction, subject to market conditions and any applicable restrictions.

How many Medpace (MEDP) shares are outstanding in relation to this Form 144 sale?

The Form 144 states that Medpace had 27,911,655 common shares outstanding. This figure provides context for the proposed 1,140-share sale, showing the filing’s transaction size relative to the company’s total shares outstanding at that time.

What Medpace (MEDP) insider sales occurred in the last three months before this Form 144?

The filing reports that 795 Medpace common shares were sold on August 7, 2026, generating aggregate proceeds of $465,131.45. This transaction is listed under securities sold during the past three months for insider Cornelius McCarthy III.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001750355
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medpace Holdings, Inc.
SEC File Number	001-37856
Address of Issuer	5375 MEDPACE WAY CINCINNATI OHIO 45227
Phone	(513) 579-9911
Name of Person for Whose Account the Securities are To Be Sold	McCarthy Cornelius P. III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1140	690121.91	27911655	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/07/2026	Stock Option Exercise	Issuer			1140	08/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Cornelius McCarthy III 5375 Medpace Way Cincinnati OH 45227	Common	08/07/2026	795	465131.45

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Cornelius Mccarthy III
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)